About Blood Stream Infection Testing The presence of bacteria and fungi in blood leads to blood stream infections. Bacteria and fungi enter into the blood and cause severe complications and infections such as pneumonia, meningitis, sepsis and AIDS. Bloodstream infections are caused when bacteria enter the bloodstream; this may occur through a wound, injection, or through a surgical procedure. Symptoms of bacteremia may include fever, chills, malaise, nausea, diarrhea, shortness of breath, and vomiting. Technavio’s analysts forecast the global blood stream infection testing market to grow at a CAGR of 7.75% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global blood stream infection testing market for 2016-2020. To calculate the market size, the report presents the vendor landscape and a corresponding detailed analysis of the top four vendors operating in the market. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Blood Stream Infection Testing Market 2016-2020, has been prepared based on an in-depth... Research Beam Model: Research Beam Product ID: 958267 2500 USD New
Global Blood Stream Infection Testing Market 2016-2020
 
 

Global Blood Stream Infection Testing Market 2016-2020

  • Category : Healthcare
  • Published On : November   2016
  • Pages : 82
  • Publisher : Technavio
 
 
 
About Blood Stream Infection Testing

The presence of bacteria and fungi in blood leads to blood stream infections. Bacteria and fungi enter into the blood and cause severe complications and infections such as pneumonia, meningitis, sepsis and AIDS. Bloodstream infections are caused when bacteria enter the bloodstream; this may occur through a wound, injection, or through a surgical procedure. Symptoms of bacteremia may include fever, chills, malaise, nausea, diarrhea, shortness of breath, and vomiting.

Technavio’s analysts forecast the global blood stream infection testing market to grow at a CAGR of 7.75% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global blood stream infection testing market for 2016-2020. To calculate the market size, the report presents the vendor landscape and a corresponding detailed analysis of the top four vendors operating in the market.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Blood Stream Infection Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• BD
• bioMérieux
• Cepheid
• Roche Diagnostics
• Thermo Fisher Scientific

Other prominent vendors
• IRIDICA
• Alere
• Beckman Coulter
• Bruker
• Nanosphere
• Siemens
• Dade Behring
• AdvanDX
• Eurogentec
• AB Sciex

Market driver
• Growing awareness of blood donation increasing the demand for BSI testing market.
• For a full, detailed list, view our report

Market challenge
• Lack of favorable reimbursement reduces adoption rate among patients.
• For a full, detailed list, view our report

Market trend
• Increasing demand for infection control committee in hospitals.
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.



Table of Content
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product
• Market overview
• Instruments
• Consumables (blood culture bottles, reagents and assay kits)
PART 07: Market segmentation by application
• Bacteremia
• Fungemia
• Mycobacteria
PART 08: Market segmentation by technology
• Market overview
• Conventional blood stream infection test
• Point of care testing (POCT)
• Nucleic acid testing
PART 09: Market segmentation by end-user
• Hospitals
• Diagnostic clinical laboratories
PART 10: Geographical segmentation
• Blood stream infection market in Americas
• Blood stream infection tests market in EMEA
• Blood stream infection tests market in APAC
PART 11: Market drivers
• Rising incidence of hospital acquired infection increases patient volume
• Patient-centered healthcare by digital technology
• Growing awareness of blood donation increasing the demand for BSI testing market
PART 12: Impact of drivers
PART 13: Market challenges
• High cost of instruments restricts market growth
• Lack of favorable reimbursement reduces adoption rate among patients
• Stringent regulatory policies restrict entry of new technologies
PART 14: Impact of drivers and challenges
PART 15: Market trends
• Focus on early diagnosis
• Technologically advanced tests save time and cost
• Increasing demand for infection control committee in hospitals
PART 16: Vendor landscape
• Competitive scenario
• BD
• bioMérieux
• Cepheid
• Roche Diagnostics
• Thermo Fisher Scientific
• Other prominent vendors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
?




List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Mortality rate of community acquired blood stream infections per year in different regions
Exhibit 03: Global blood stream infection testing market 2015-2020 ($ millions)
Exhibit 04: Global blood stream infection testing market overview
Exhibit 05: Five forces analysis
Exhibit 06: Global blood stream infection testing market by products 2015-2020 (%)
Exhibit 07: Market strategy analysis of instruments segment
Exhibit 08: Global blood stream infection testing instruments market 2015-2020 ($ millions)
Exhibit 09: Market strategy analysis of consumable segment
Exhibit 10: Global blood stream infection testing consumables market 2015-2020 ($ millions)
Exhibit 11: Top ten bacterimia blood stream infections in 2015
Exhibit 12: Global blood stream infections testing market by products
Exhibit 13: Global blood stream infection testing market share by technology 2015-2020 (%)
Exhibit 14: Global conventional blood stream infection testing market 2015-2020 ($ millions)
Exhibit 15: The laboratory and POC testing process
Exhibit 16: Global blood stream infection testing market by end-user 2015-2020 (%)
Exhibit 17: Blood stream infection testing market revenue in the Americas 2015-2020 ($ millions)
Exhibit 18: Blood stream infection testing market in Americas
Exhibit 19: Blood stream infection testing market revenue in EMEA 2015-2020 ($ millions)
Exhibit 20: Blood stream infection testing market in EMEA
Exhibit 21: Blood stream infection testing market revenue in APAC 2015-2020 ($ millions)
Exhibit 22: Blood stream infection testing market in APAC
Exhibit 23: Impact of driver
Exhibit 24: Price of different sequencers of different companies
Exhibit 25: Government regulatory stages of blood stream infection devices and consumables
Exhibit 26: Impact of drivers and challenges
Exhibit 27: Reasons for hospital acquired blood stream infection
Exhibit 28: Competitive structure of vendors in blood stream infection testing market
Exhibit 29: Strength assessment
Exhibit 30: BD: Strategy assessment
Exhibit 31: BD opportunity assessment
Exhibit 32: bioMérieux strength assessment
Exhibit 33: bioMérieux strategy assessment
Exhibit 34: bioMérieux: Opportunity assessment
Exhibit 35: Cepheid: Strength assessment
Exhibit 36: Cepheid: Strategy assessment
Exhibit 37: Cepheid opportunity assessment
Exhibit 38: Roche Diagnostics: Strength assessment
Exhibit 39: Roche Diagnostics: Strategy assessment
Exhibit 40: Roche Diagnostics: Opportunity assessment
Exhibit 41: Thermo Fisher Scientific: Strength assessment
Exhibit 42: Thermo Fisher Scientific: Strategy assessment
Exhibit 43: Thermo Fisher Scientific: Opportunity assessment

PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT